Clinical trial
Drug Use Investigation of Fosrenol for Hyperphosphatemia With Chronic Kidney Disease Not on Dialysis
NCT01955876 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Drug Use Investigation of Fosrenol for Hyperphosphatemia With Chronic Kidney Disease Not on Dialysis
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 10, 2013
- Completion date
- August 5, 2016
- Enrollment
- 343 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hyperphosphatemia, kidney disease